Health Response-Based Ponatinib Dose Reduction a Win-Win in Chronic-Phase CML? Eli Pacheco Sep 30, 2022 0 For patients with chronic-phase chronic myeloid leukemia (CML), a response-based dose-reduction strategy for ponatinib (Iclusig)…
